FOXM1 and cancer: The overexpression of miR-149 increased the drug sensitivity of cancer cells and inhibited the EMT through the FOXM1/cyclin D1/MMP2 axis (Ke et al., 2013; Xu et al., 2015; Sun et al., 2018).